本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

UNIVERSAL BIOSENSORS INC-CDI

0.021
-0.002-8.70%
成交量:12.39萬
成交額:2,603.00
市值:625.94萬
市盈率:-0.33
高:0.022
開:0.022
低:0.021
收:0.023
52周最高:0.160
52周最低:0.017
股本:2.98億
流通股本:1.92億
量比:0.28
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-0.063
每股收益(LYR):-0.053
淨資產收益率:-110.97%
總資產收益率:-52.10%
市淨率:0.88
市盈率(LYR):-0.40

資料載入中...

公司資料

公司名字:
UNIVERSAL BIOSENSORS INC-CDI
交易所:
ASX
成立時間:
2001
員工人數:
76
公司地址:
1 Corporate Avenue,Rowville,Victoria,Australia
郵編:
3178
傳真:
61 3 9213 9099
簡介:
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, designs and develops electrochemical cells in Australia. The company focuses on the research, development, and manufacture of medical or testing devices. It uses electrochemical cell technology platform to develop point of use devices for various industries, including healthcare, food and drink, and agriculture. The company offers prothrombin time international normalized ratio coagulation test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. It also owns, operates, and manages a hemostasis laboratory. The company was founded in 2001 and is based in Rowville, Australia.